Name | 4,4-Dimethyl-1-(3-nitro-phenyl)-2-[1,2,4]triazol-1-yl-pent-1-en-3-one |
---|---|
Synonyms |
(1Z)-4,4-dimethyl-1-(3-nitrophenyl)-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-one
4,4-Dimethyl-1-(3-nitro-phenyl)-2-[1,2,4]triazol-1-yl-pent-1-en-3-one (1Z)-4,4-Dimethyl-1-(3-nitrophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-penten-3-one MFCD00219515 1-Penten-3-one, 4,4-dimethyl-1-(3-nitrophenyl)-2-(1H-1,2,4-triazol-1-yl)-, (1Z)- 4,4-dimethyl-1-(3-nitrophenyl)-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-one (Z)-4,4-Dimethyl-1-(3-nitro-phenyl)-2-[1,2,4]triazol-1-yl-pent-1-en-3-one |
Description | Nexinhib 20 is a novel small molecule neutrophil exocytosis inhibitor (IC50=0.33 uM) that specifically inhibits Rab27a-JFC1 binding (IC50=2.6 uM) but does not interfere with the interaction of other Rab GTPases and effectors; does not induce apoptosis or cell death, regulates exocytosis-dependent neutrophil functions and inhibits MPO secretion from human neutrophils; also reversiblely and potently inhibits extracellular production of superoxide anion and the up-regulation of activation signature molecules, including CD11b and CD66b; significantly decreased tissue infiltration by inflammatory neutrophils in vivo. |
---|---|
References | References 1. Johnson JL, et al. J Biol Chem. 2016 Dec 9;291(50):25965-25982. View Related Products by Target Small GTPase |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 508.2±60.0 °C at 760 mmHg |
Molecular Formula | C15H16N4O3 |
Molecular Weight | 300.313 |
Flash Point | 261.2±32.9 °C |
Exact Mass | 300.122253 |
LogP | 2.50 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.601 |